Issue: August 2016
August 01, 2016
1 min read
Save

Trial Scorecard: CHANCE

Issue: August 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers conducted a subgroup analysis to determine if genetic variants played a role in clopidogrel effectiveness after minor stroke or transient ischemic attack.

Trial Scorecard: CHANCE